An interventional study of Lightweight mesh fixation in 3 points or 1 point in Inguinal Hernia, Chronic Pain and Seroma, sponsored by Nanchong Central Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-09.
Sponsored by Nanchong Central Hospital · Not applicable, Interventional, and Treatment
This study was designed to compare the outcome of 3 point with 1 point lightweight mesh fixation in TAPP surgery for patients with inguinal hernia. The main outcome include seroma, chronic pain, recurrence, et al.
543 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.
This study's enrollment of 351 is above the median of 90 across 395 interventional studies indexed under Hernia, Inguinal.
Browse Hernia, Inguinal studies →Nanchong Central Hospital is the lead sponsor of 20 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The inclusion criteria were as follows: primary inguinal hernia.
Exclusion Criteria:
Patients not suitable for general anesthesia. Patients requiring open surgery; patients requiring emergency surgery Loss to follow-up or communication difficulties, or poor compliance.
Using 3-0 absorbable sutures, the mesh was secured at three key anatomical landmarks: (1) the posterior rectus sheath medially, (2) the pubic pectineal ligament (Cooper's ligament) inferiorly, and (3) the lateral edge of the iliopubic tract.
Procedure: Lightweight mesh fixation in 3 points or 1 point
Using 3-0 absorbable sutures, the mesh was secured at one of the following key anatomical landmarks: (1) the posterior rectus sheath medially, (2) the pubic pectineal ligament (Cooper's ligament) inferiorly, or (3) the lateral edge of the iliopubic tract. The fixation site was selected based on the most prominent anatomical landmark, with preference given to the pubic pectineal ligament (Cooper's ligament) or the lateral edge of the iliopubic tract.
Procedure: Lightweight mesh fixation in 3 points or 1 point
Lightweight mesh fixation in 3 points
Rate of postoperative pain
The visual analog scale (VAS) was adopted for pain evaluation 1 day, 7 days, 1 month, 3 months, 6 months and 12 months postoperatively. The scale range from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain.
Time frame: 12 months
Rate of recurrence
Hernia recurrenceFollow up by physical examination, ultrasonography and telephone at 1 month,3 months,6 months and 12 months after surgery about the rate of hernia recurrence.
Time frame: 1 month,3 months,6 months and 12 months after surgery
Rate of postoperative complications
Including infection, seroma, hematoma
Time frame: 12 months
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2023 to primary completion in Oct 2025, 33 months.
Of 177 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 33 months is above that.
Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanchong Central Hospital